CAMP Q3 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93M-2.9% YoY

Gross Profit

$38M40.4% margin

Operating Income

-$5M-4.9% margin

Net Income

-$7M-7.9% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$594,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$659M

Total Liabilities

$466M

Stockholders' Equity

$193M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$96M	-2.9%
Gross Profit	$38M	$40M	-5.4%
Operating Income	-$5M	$4M	-208.4%
Net Income	-$7M	-$854,000	-762.9%

Revenue Segments

Product

$62M67%

Application Subscriptions And Related Products And Service

$31M33%

Geographic Segments

UNITED STATES

$69M74%

E M E A

$13M14%

Latin America

$4M5%

All Other

$3M3%

CANADA

$2M3%

Asia Pacific

$2M2%